Purpose: The United States is in the midst of a severe opioid use disorder epidemic. Buprenorphine is an effective office-based treatment that can be prescribed by physicians, nurse practitioners, and physician assistants with a Drug Enforcement Administration (DEA) waiver. However, many providers report barriers that keep them from either getting a DEA waiver or fully using it. The study team interviewed rural physicians successfully prescribing buprenorphine to identify strategies for overcoming commonly cited barriers for providing this service.
Buprenorphine is an effective medication-assisted treatment (MAT) option that can be provided in an officebased setting 4 rather than in a certified opioid treatment program, which is required for methadone and largely unavailable in rural places. 5, 6 Despite the substantial growth in the number of providers with a DEA waiver, access to treatment remains difficult for many people, especially those who live in rural areas. 6 Numerous studies show that many waivered physicians are not using their waiver to its full extent or at all, contributing to the lack of treatment access across the country. [7] [8] [9] Providers with a DEA waiver frequently report challenges and barriers to incorporating this service into their practice [10] [11] [12] ; however, despite these challenges, many physicians report being able to successfully add and provide MAT services to their practices. The purpose of this study, to our knowledge the first of its kind, was to identify and interview physicians who are providing MAT to a large number of patients to learn strategies and best practices for adding and providing MAT in rural areas.
Methods

Setting
Potential interview participants were selected from respondents to a 2016 WWAMI i Rural Health Research Center (RHRC) survey of 2,577 rurally located physicians with a DEA waiver to prescribe buprenorphine for the treatment of OUD (C.H.A., unpublished data, 2016). 10 
Sampling and Recruitment
Based on the April 2016 DEA list of waivered providers, 13 physician respondents were identified as having either a 30-or a 100-patient waiver. Of the 698 rural physician survey respondents with a 30-patient waiver, the 75 physicians that were treating 25 patients or more were selected. Of the 523 rural physicians with the 100-patient waiver, the 211 physicians that were in the top half of prescribers, treating 60 patients or more, were selected. Within both waiver strata of the 286 eligible interview candidates, physicians were ordered using a random number generator.
Beginning December 1, 2017, letter invitations were sent out, in order, to selected physicians of both waiver types in groups of either 5, 10 or 20, roughly once a week. The letter included a description and purpose of the study, an invitation to participate in a telephone interview, and notice that the research center would be phoning them. The letter included a mail-back invitation response form and prepaid return envelope that physicians could complete and return to expedite interview scheduling.
Eleven rounds, equaling 137 letters, were sent to identified physicians. Regardless of whether a mail-back form was returned, attempts to contact and schedule an interview with each physician were made up to 5 times over a 4-month period. To obtain a representative sample, target numbers of interviewees from each US Census Division were calculated based on a preliminary estimate of needing approximately 35 interviews to reach content saturation. Once the target number for a Census Division was reached, no further letters were sent to physicians from that Census Division.
The interviewers (Andrilla, Moore, and Patterson) had no previous relationships with the participants.
Interview Instrument
Telephone interviews of approximately 20 minutes were conducted using a semistructured interview guide that allowed for follow-up questions based on physician responses (available online only). The interview guide included questions about the physician's practice environment, patient population, and specialty. Physicians were asked if they had had to turn away patients seeking MAT for any reason. Physicians were prompted to discuss if and how they had overcome the barriers to prescribing buprenorphine asked about on the WWAMI RHRC 2016 survey. These barriers included time constraints, financial/reimbursement concerns, practice partners' resistance, lack of specialty backup for complex problems, lack of confidence in their ability to manage OUD, lack of available mental health/psychosocial support services, attraction of drug users to their practice, DEA intrusion on their practice, and concerns about diversion/misuse of medication. Finally, physicians were asked if they had anything else to add or any advice for providers who are considering adding MAT to their practice. Interviews were audio recorded for transcription purposes.
Data Analysis
Interview recordings were transcribed and 2 authors (Andrilla and Moore) conducted a directed content analysis to identify main themes, successful strategies, and recommendations to overcome each of the queried barriers and any new ones offered by respondents.
14 The 2 authors resolved coding discrepancies to achieve 100% agreement. After 36 interviews, no new strategies were reported; upon completing 7 additional interviews, for a total of 43, we concluded that saturation had been reached.
T-tests and chi-square analysis were used to compare the demographic and practice characteristics of interviewed physicians to the respondents of the 2016 WWAMI RHRC survey to ensure a representative sample. Analysis was performed using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). This study was determined "Exempt" from human subjects review by the University of Washington Human Subjects Division.
Results
The average age of participants was 55.6 years, about two-fifths (39.5%) were over age 65 (Table 1) . Threequarters (74.4%) were men. The most common specialty was family medicine (39.5%). Other specialties reported included psychiatry (16.3%), internal medicine (14.0%), and addiction medicine (14.0%). More than half (58.1%) of participants worked in private practice, 11.6% in hospital-sponsored clinics, 14.0% in Community Health Centers or Veteran's Affairs Facilities, and 7.0% in Rural Health Clinics. Almost half (48.8%) held a DEA waiver allowing treatment of up to 100 patients concurrently, 41.9% had a waiver allowing treatment of up to 275 patients, and 9.3% held the initial waiver allowing treatment of up to 30 patients. Participants did not differ significantly in age, gender, practice setting, or Census Region from the respondents to the 2016 survey of rural physicians with a DEA waiver.
Key themes and subthemes are summarized in Table 2 and reported with illustrative quotes.
Getting Started
Many interviewed physicians believed that problems associated with getting started as a MAT provider posed significant deterrents for providers, and that it was important to find solutions to combat these barriers. Several strategies were identified that eased the burden of getting started.
Finding a Mentor
Physicians reported that having a mentor to answer questions and provide support made initially incorporating MAT into the practice much easier. Mentoring I would recommend to spend 1 hour talking to someone who has already been doing this for a while somewhere else. Because it would seem daunting, and would be probably discouraging to try to sort of reinvent the wheel on your own, and sort of figure out how to have really firm boundaries in certain areas and how to have an efficient way of doing this . . . You wouldn't have the frustrations that we've had as we were developing our program.
They need to get a mentor through PCSS. I did that for a while, my first couple of years. I would go over problem cases about the patients with the mentor. Or even get somebody in person that's in their area to work with them because you kind of have to have a strategy for how you deal with all these different abnormal drug tests that you run into, you almost have to have a strategy for every scenario of breaking the contract . . . there are a lot of different questions.
Starting with Only a Few Patients
The initial buprenorphine waiver that providers can obtain stipulates a maximum patient load of 30. Physicians reported that 30 patients can be overwhelming when a provider is just starting and recommended that providers only take on a few, well-vetted patients in the beginning. This gives the provider time to get accustomed to the prescribing schedule, appointment structure, and required paperwork. Starting slowly and taking on patients without severe comorbidities allowed physicians to ease into this part of their practice and gain confidence before increasing their patient load. In the family practice setting specifically, physicians recommended first prescribing only to known patients in the practice.
Setting Aside a Discrete Amount of Time
The degree to which time constraints were a barrier varied substantially by setting. However, most physicians found that setting aside a discrete amount of time for buprenorphine treatment, especially in the beginning, helped them stay in control of the program and not feel overwhelmed. This was especially true for physicians who were adding MAT services to an already established family practice and who were worried it would take over their entire practice if left to grow unrestricted. The amount of time dedicated to MAT services varied considerably by provider, from 1 day a month to 6 days a week. However, the specific amount of time did not seem to matter as much as explicit acknowledgement of the limitations of their services and their workplaces and careful determination of the amount of time available for providing MAT treatment, while maintaining high quality of care across all patient populations.
Maintaining MAT Services
Numerous comments clustered around the key theme of strategies for maintaining MAT. Physicians reported strategies that they have used to effectively sustain this service.
Using a Contract
Almost all physicians reported having patients sign a treatment contract or agreement. The contract outlined the expectations of the patient, for example, keeping appointments, submitting to random drug urine tests or pill counts, treating the clinical staff and other patients with respect, not selling or misusing their prescription, and being honest about drug use. The contract usually defined the consequences if any of the outlined stipulations were violated and which offenses resulted in a stricter treatment plan versus termination from the program. Physicians reported that both provider and patient benefited from having these firm and transparent boundaries. The contract gave the patient clear expectations from the beginning of the treatment and helped support the physician if termination was necessary. Physicians varied significantly in how they dealt with contract violations, some believed mistakes were expected and allowed, while others believed that any breach in contract should result in termination. What seemed to be important was that those expectations and consequences were laid out clearly from the beginning and strictly adhered to.
They appreciate accountability, and this is a particular area where you need accountability. They appreciate boundaries more when you hold them accountable.
I think it's important to lay down the rules, the algorithm, in writing so the patient can read it and agree upon it and the physician can read it and agree upon it, and then when the policy is not followed, when the policy is violated, go ahead and have the consequences set out for that violation of the policy. Now the consequences come in the form of increased/enhanced therapy, it's not a punishment . . . It needs to be set up in a way that when what we do is failing, we need to increase the level of care.
Establishing Boundaries
Most physicians reported that being strict and straightforward with their patients was crucial. They reported having to establish boundaries in the beginning and maintaining them throughout the treatment program. Physicians said it was their job to hold both the patients and themselves accountable. They advised that if patients started to cross boundaries, it was a "slippery slope" that made it much harder for the physician to maintain control of the treatment program. Physicians noted that in small and rural communities word can travel quickly, and if a physician is known to be inconsistent, people may seek them out and try to take advantage of them and abuse their access to buprenorphine. To maintain the respect and authority necessary to provide this treatment, physicians said they had to adamantly follow the initial rules and boundaries they establish.
If you're not going to hold people accountable, then don't do this work.
Because of our reputation, people won't show up if they want to play games-they will go elsewhere.
Laying down the ground rules in the beginning, what's going to be allowed and not allowed, and being really strict on it in the beginning, that's probably the most important thing.
Terminating Treatment
An overwhelming majority of physicians acknowledged that it was sometimes necessary to terminate a patient's treatment program, indicating that this was part of the reason it was so important to have patients sign a contract when they first began treatment. They felt that if the program was not helping a patient get better, then the patient needed to be referred to a higher level of care. Physicians reported that termination could be a hard decision, especially in rural areas with limited access to more intensive treatment options, but if a patient was not responding to the treatment and the physician was getting burnt out, then termination was necessary. Many physicians reported that they would still provide primary care to that patient, but not MAT. Many physicians also reported that they would consider taking terminated patients back if they showed marked improvements in their commitment to recovery.
I don't discharge a patient for, by any means, a single relapsed urine specimen or relapse by history. But eventually if patients over and over and over again are indicating relapse, then we'll have to disengage them, and that doesn't happen too often.
Implementing the "Hub and Spoke" Model
In several states across the country, practice groups are beginning to incorporate the "Hub and Spoke" model, which designates a few larger clinics as hubs and many smaller clinics as spokes. Hubs are usually in larger cities and have greater resources and inpatient treatment capacity. Spokes are in more rural areas, and are smaller extensions of the hubs. The model provides clinicians in the spokes increased practice support and the ability to refer patients to higher levels of care if needed. Physicians found this model to be especially effective for the treatment of OUD with MAT, allowing them to take on a patient seeking MAT treatment with the ability to refer to a higher level of care if the patient required more extensive treatment than the spoke could provide.
Complying with DEA Requirements
In the 2016 survey, physicians reported a concern that the Drug Enforcement Administration (DEA) would intrude on their practice if they became waivered to prescribe buprenorphine for the treatment of OUD. 10 Physicians in this study identified ways to deal with these concerns and minimize negative interactions with the DEA.
Following the Rules and Keeping Detailed Records
Concerns that the DEA would intrude on the physician's practice varied considerably among the interviewed physicians. Those who were worried about the DEA tended to have had previous negative interactions with the agency, while those who were not worried had only positive or neutral interactions with the DEA. Regardless of past experiences, all physicians recommended that providers follow all DEA rules strictly (available on the DEA 15 and SAMHSA 16 websites), keep detailed records, and be prepared for the DEA to visit. Physicians who reported strictly following these rules did not report being concerned about the DEA.
I fully expect that at some point we will be audited, I feel like that's fine. The DEA is the one who gave me the license, so it's kind of at their discretion if they want to review it, so I have no problems with that.
We try to keep as good of records as possible. When they made their first visit the fellows that came over from the Boise area were very nice and made several suggestions, otherwise they kind of left me alone.
Ensuring Financial Viability
Physicians varied significantly in their opinions about whether financial and reimbursement concerns were a barrier. The majority, however, reported that their state's Medicaid reimbursement amount was too low given the time required to treat these patients. From there, physicians diverged in their approach: some decided to accept cash only to avoid this financial burden, while others were able to "take the financial hit" by accepting Medicaid payment. This issue was further complicated by a physician's practice setting. In an established practice that accepted Medicaid for other services, physicians were required to accept it for MAT, in practices that only provided MAT and other substance abuse services, the clinic was more easily able to accept cash only for all services. Several physicians reported high success accepting only cash and private insurance along with a sliding fee scale that ensured all patients seeking treatment would be able to afford it.
I have just taken the hit because the medication works, I've seen people get better, and that's why I went into medicine in the first place.
Medicaid-it's just a pain to submit prior authorizations and stuff like that, but we have kind of gotten that system down, where we can do that. And I think the reimbursement for Medicaid in our area has been at least adequate to the job. I do not feel like we are losing a lot of money on seeing those Suboxone patients.
Combatting Diversion and Misuse
The most common barrier in providing MAT treatment, reported by almost half of rural physicians, was concern about diversion and misuse of the medication. 10 Physicians in this study employed numerous strategies to overcome this barrier, including random pill counts, urine drug screens, use of state prescription drug monitoring programs, developing relationships with local pharmacies, checking local police blotters, and investigating allegations from community members. Many physicians indicated that patients were required to bring their medication and medication wrappers to their appointments to ensure that patients had the appropriate number of pills or buprenorphine strips. Exchanging information with local pharmacies allowed for verification that the serial numbers on the medication wrappers that patients brought to their appointments matched those dispensed at the pharmacy to that particular patient. Submitting to random pill counts and drug screens was a part of almost every physician's patient contract, and physicians and/or their staff cited procedures for random 24-hour-notice medication checks to minimize diversion concerns. Although all physicians acknowledged that misuse and diversion were possibilities, with strict tracking and testing, physicians found that the benefit of providing MAT outweighed the possible risk of diversion.
Ensuring Access to Mental Health Services
Lack of mental health and psychosocial support was the second most frequently named barrier among rural physicians with a DEA waiver in 2016. 10 Physicians in this study overcame this challenge in a variety of ways. Most, but not all, physicians required patients to participate in counseling at least during the beginning of treatment. Some physicians provided counseling themselves during the patient's standard visit. Others had started group counseling sessions in their office that all MAT patients were required to attend. Most believed that community and faith treatment groups such as Narcotics Anonymous met this requirement, and they were reported to be free, often easy-to-access options. Some physicians had also created relationships with mental health providers, either local or afar, that provided the prescribing physician with psychosocial support for complex patients. Several physicians indicated that patients could "graduate" from the counseling requirement after they had been successful in their recovery for a specified period of time.
Overcoming Stigma
Physicians identified a new barrier that was not on the interview guide. Several physicians reported that stigma surrounding substance use disorders was one of the greatest barriers they encountered when trying to add MAT to their practices. Many physicians encountered resistance from other physicians or medical staff in their practices, posing a challenge for physicians to add this service and creating an unwelcome feeling for patients seeking this service. Resistance within a practice was usually because of the fear of attracting drug users or the belief that OUD treatment should not involve substituting one opioid for another. Some physicians also reported that pharmacies treated their patients badly or simply refused to carry the medication, further ostracizing patients seeking MAT treatment. Most interviewees reported overcoming this barrier by having open and honest dialogues with their colleagues and staff, and by humanizing the patients, such as encouraging people to shadow them, observe the treatment process, and meet patients. Others created close relationships with local pharmacists that allowed for problems to be addressed quickly and directly. The vast majority of family practice physicians reported that adding this service did not attract new drug users to their practice, instead, patients with substance use disorders were already in their practice and were simply not receiving the full level of care they needed. Many physicians stated that the stigma surrounding substance abuse deterred both patients and providers from adopting this service and needed to be better addressed.
It's part of the whole overall health of their patients. If they're not addressing this, they're missing one of the major health problems that a patient has.
These patients are discriminated at the pharmacies. It takes tremendous courage to even admit they need help; then when they get the help, if they go to a pharmacy to fill the medication . . . some pharmacies, pharmacists, staff workers, they're not nice to these patients. And [patients] said ''you know it would be a lot easier, I'd be treated a lot nicer if I was getting pain medication maybe.''
Doing Rewarding Work
Despite the barriers and challenges that the interviewed physicians reported, most found the work highly rewarding and fulfilling.
It's the most satisfying, personally nourishing medical activity I've done in my practice lifetime. This is by far the most rewarding area of medicine I have ever practiced in.
In addition to the personal satisfaction that physicians reported, many shared their feelings about seeing changes in patients' lives.
No one gets excited because their blood pressure is under control, or their diabetes is better, but the addiction patient that gets better, it just has ripple effects through the community. It keeps families together, moms and children and grandparents are all much happier, so it's much more rewarding in a lot of ways than routine family practice.
The biggest success stories that I have are family, family dynamics, families that come together to heal again, those are the best stories of all I have to say. And they're worth it.
Physicians also expressed pleasure being part of the solution to addressing the opioid epidemic and encouraged other physicians to obtain a waiver and provide this service.
I tell them you must, you must. You did it, I did it, we all did it, we are all in this together, and now we need to help fix it.
I am really proud to be part of the solution.
Limitations
This study has some limitations. Physicians who agreed to participate in the study interview did not differ from the WWAMI 2016 survey respondents on numerous factors, but their specialties were different. A greater proportion of physicians who were addiction medicine specialists participated, likely because under CARA legislation, an addiction medicine credential qualifies a physician to treat more OUD patients regardless of practice location. 3 Although our respondents mirrored the Census Region distribution of rural physicians with a DEA waiver, we did not have an adequate sample size to statistically test the distribution at the Census Division level. This may be important because the rate that physicians reported some barriers did vary by Census Division in the prior study from which this study's sample was drawn. 10 Despite these limitations, the themes and strategies to overcoming barriers for providing MAT treatment reported by physicians were consistent across this group of providers and with strategies that have been reported elsewhere. [17] [18] [19] The Journal of Rural Health 35 (2019) 113-121 c 2018 National Rural Health Association
Discussion and Conclusions
Many rural physicians around the country have been able to successfully incorporate MAT treatment into their practices, despite the numerous barriers that have been previously cited. [10] [11] [12] This study's findings on the practices of waivered providers who have successfully incorporated MAT into their practices may be useful to providers considering offering MAT to their patients. Many providers are concerned that providing MAT services will take over their practices in terms of time, money, and paperwork, because of the number of patients needing this care. 17 The results of this study strongly suggest that, while there are challenges, they can be overcome with a careful, considered approach, guided by mentors and effective use of tools such as patient contracts. At the end of 2017, there were 33,876 waivered physicians, 3,534 waivered NPs, and 912 waivered PAs, representing only 3.7%, 1.7%, and 0.8% of eligible physicians, NPs, and PAs, respectively. [20] [21] [22] A modest increase in the number of actively prescribing waivered providers has potential to substantially increase the number of patients treated and more evenly distribute the responsibility of care.
Practice capabilities and available resources vary significantly by provider and setting. No single solution will work for every provider seeking to add MAT services; however, by learning from the frameworks and practices adopted by successful prescribing providers, all providers should be able to establish a practice model that will allow them to successfully treat, at the minimum, patients already established in their practice. 
